nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—ABCB1—hematologic cancer	0.144	1	CbGaD
Reboxetine—ABCB1—Lenalidomide—hematologic cancer	0.0283	0.0527	CbGbCtD
Reboxetine—CYP2D6—Lomustine—hematologic cancer	0.0248	0.0462	CbGbCtD
Reboxetine—CYP2D6—Idarubicin—hematologic cancer	0.0221	0.0412	CbGbCtD
Reboxetine—CYP2D6—Hydroxyurea—hematologic cancer	0.0188	0.035	CbGbCtD
Reboxetine—CYP3A4—Bexarotene—hematologic cancer	0.017	0.0316	CbGbCtD
Reboxetine—ABCB1—Daunorubicin—hematologic cancer	0.0166	0.0309	CbGbCtD
Reboxetine—CYP2D6—Bortezomib—hematologic cancer	0.0163	0.0304	CbGbCtD
Reboxetine—ABCB1—Alitretinoin—hematologic cancer	0.0163	0.0303	CbGbCtD
Reboxetine—CYP3A4—Lomustine—hematologic cancer	0.0158	0.0294	CbGbCtD
Reboxetine—CYP3A4—Busulfan—hematologic cancer	0.0158	0.0294	CbGbCtD
Reboxetine—CYP3A4—Thiotepa—hematologic cancer	0.0141	0.0262	CbGbCtD
Reboxetine—ABCB1—Imatinib—hematologic cancer	0.0127	0.0237	CbGbCtD
Reboxetine—CYP2D6—Imatinib—hematologic cancer	0.012	0.0223	CbGbCtD
Reboxetine—ABCB1—Nilotinib—hematologic cancer	0.0116	0.0215	CbGbCtD
Reboxetine—ABCB1—Vinorelbine—hematologic cancer	0.0115	0.0213	CbGbCtD
Reboxetine—CYP3A4—Methoxsalen—hematologic cancer	0.0109	0.0204	CbGbCtD
Reboxetine—CYP2D6—Nilotinib—hematologic cancer	0.0109	0.0203	CbGbCtD
Reboxetine—CYP2D6—Vinorelbine—hematologic cancer	0.0108	0.0201	CbGbCtD
Reboxetine—CYP3A4—Bortezomib—hematologic cancer	0.0104	0.0194	CbGbCtD
Reboxetine—ABCB1—Dasatinib—hematologic cancer	0.0102	0.019	CbGbCtD
Reboxetine—ABCB1—Mitoxantrone—hematologic cancer	0.0101	0.0188	CbGbCtD
Reboxetine—CYP3A4—Daunorubicin—hematologic cancer	0.00994	0.0185	CbGbCtD
Reboxetine—ABCB1—Betamethasone—hematologic cancer	0.00899	0.0167	CbGbCtD
Reboxetine—ABCB1—Gemcitabine—hematologic cancer	0.00891	0.0166	CbGbCtD
Reboxetine—ABCB1—Prednisolone—hematologic cancer	0.00887	0.0165	CbGbCtD
Reboxetine—CYP3A4—Cytarabine—hematologic cancer	0.00877	0.0163	CbGbCtD
Reboxetine—CYP3A4—Teniposide—hematologic cancer	0.00864	0.0161	CbGbCtD
Reboxetine—ABCB1—Prednisone—hematologic cancer	0.00838	0.0156	CbGbCtD
Reboxetine—CYP3A4—Ifosfamide—hematologic cancer	0.00797	0.0148	CbGbCtD
Reboxetine—ABCB1—Irinotecan—hematologic cancer	0.00794	0.0148	CbGbCtD
Reboxetine—CYP3A4—Imatinib—hematologic cancer	0.00762	0.0142	CbGbCtD
Reboxetine—CYP3A4—Ruxolitinib—hematologic cancer	0.00717	0.0134	CbGbCtD
Reboxetine—ABCB1—Vinblastine—hematologic cancer	0.00706	0.0131	CbGbCtD
Reboxetine—ABCB1—Vincristine—hematologic cancer	0.00694	0.0129	CbGbCtD
Reboxetine—CYP3A4—Nilotinib—hematologic cancer	0.00692	0.0129	CbGbCtD
Reboxetine—CYP3A4—Vinorelbine—hematologic cancer	0.00686	0.0128	CbGbCtD
Reboxetine—CYP2D6—Vinblastine—hematologic cancer	0.00665	0.0124	CbGbCtD
Reboxetine—ABCB1—Cisplatin—hematologic cancer	0.00647	0.0121	CbGbCtD
Reboxetine—ABCB1—Etoposide—hematologic cancer	0.00636	0.0118	CbGbCtD
Reboxetine—CYP3A4—Triamcinolone—hematologic cancer	0.00628	0.0117	CbGbCtD
Reboxetine—CYP3A4—Dasatinib—hematologic cancer	0.00612	0.0114	CbGbCtD
Reboxetine—CYP3A4—Mitoxantrone—hematologic cancer	0.00604	0.0113	CbGbCtD
Reboxetine—CYP3A4—Betamethasone—hematologic cancer	0.00539	0.01	CbGbCtD
Reboxetine—CYP3A4—Prednisolone—hematologic cancer	0.00531	0.0099	CbGbCtD
Reboxetine—ABCB1—Dexamethasone—hematologic cancer	0.00523	0.00974	CbGbCtD
Reboxetine—CYP3A4—Prednisone—hematologic cancer	0.00502	0.00935	CbGbCtD
Reboxetine—CYP2D6—Dexamethasone—hematologic cancer	0.00493	0.00917	CbGbCtD
Reboxetine—CYP3A4—Irinotecan—hematologic cancer	0.00476	0.00886	CbGbCtD
Reboxetine—ABCB1—Doxorubicin—hematologic cancer	0.00434	0.00808	CbGbCtD
Reboxetine—CYP3A4—Vinblastine—hematologic cancer	0.00423	0.00788	CbGbCtD
Reboxetine—ABCB1—Methotrexate—hematologic cancer	0.0042	0.00783	CbGbCtD
Reboxetine—CYP3A4—Vincristine—hematologic cancer	0.00416	0.00774	CbGbCtD
Reboxetine—CYP2D6—Doxorubicin—hematologic cancer	0.00409	0.00761	CbGbCtD
Reboxetine—CYP3A4—Etoposide—hematologic cancer	0.00381	0.0071	CbGbCtD
Reboxetine—CYP3A4—Dexamethasone—hematologic cancer	0.00313	0.00583	CbGbCtD
Reboxetine—CYP3A4—Doxorubicin—hematologic cancer	0.0026	0.00484	CbGbCtD
Reboxetine—Tinnitus—Epirubicin—hematologic cancer	3.15e-05	0.000114	CcSEcCtD
Reboxetine—Malnutrition—Methotrexate—hematologic cancer	3.14e-05	0.000114	CcSEcCtD
Reboxetine—Headache—Gemcitabine—hematologic cancer	3.14e-05	0.000114	CcSEcCtD
Reboxetine—Nausea—Vincristine—hematologic cancer	3.14e-05	0.000114	CcSEcCtD
Reboxetine—Cardiac disorder—Epirubicin—hematologic cancer	3.14e-05	0.000113	CcSEcCtD
Reboxetine—Rhinitis—Doxorubicin—hematologic cancer	3.13e-05	0.000113	CcSEcCtD
Reboxetine—Hypersensitivity—Prednisolone—hematologic cancer	3.11e-05	0.000112	CcSEcCtD
Reboxetine—Pharyngitis—Doxorubicin—hematologic cancer	3.1e-05	0.000112	CcSEcCtD
Reboxetine—Dyspepsia—Dexamethasone—hematologic cancer	3.1e-05	0.000112	CcSEcCtD
Reboxetine—Dyspepsia—Betamethasone—hematologic cancer	3.1e-05	0.000112	CcSEcCtD
Reboxetine—Urinary tract disorder—Doxorubicin—hematologic cancer	3.09e-05	0.000112	CcSEcCtD
Reboxetine—Urticaria—Triamcinolone—hematologic cancer	3.09e-05	0.000112	CcSEcCtD
Reboxetine—Dysgeusia—Methotrexate—hematologic cancer	3.08e-05	0.000111	CcSEcCtD
Reboxetine—Asthenia—Etoposide—hematologic cancer	3.07e-05	0.000111	CcSEcCtD
Reboxetine—Connective tissue disorder—Doxorubicin—hematologic cancer	3.07e-05	0.000111	CcSEcCtD
Reboxetine—Body temperature increased—Triamcinolone—hematologic cancer	3.07e-05	0.000111	CcSEcCtD
Reboxetine—Angiopathy—Epirubicin—hematologic cancer	3.07e-05	0.000111	CcSEcCtD
Reboxetine—Urethral disorder—Doxorubicin—hematologic cancer	3.06e-05	0.000111	CcSEcCtD
Reboxetine—Decreased appetite—Betamethasone—hematologic cancer	3.06e-05	0.000111	CcSEcCtD
Reboxetine—Decreased appetite—Dexamethasone—hematologic cancer	3.06e-05	0.000111	CcSEcCtD
Reboxetine—Nausea—Mitoxantrone—hematologic cancer	3.06e-05	0.000111	CcSEcCtD
Reboxetine—Nausea—Irinotecan—hematologic cancer	3.06e-05	0.000111	CcSEcCtD
Reboxetine—Immune system disorder—Epirubicin—hematologic cancer	3.05e-05	0.00011	CcSEcCtD
Reboxetine—Infection—Prednisone—hematologic cancer	3.05e-05	0.00011	CcSEcCtD
Reboxetine—Mediastinal disorder—Epirubicin—hematologic cancer	3.05e-05	0.00011	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.04e-05	0.00011	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.04e-05	0.00011	CcSEcCtD
Reboxetine—Chills—Epirubicin—hematologic cancer	3.03e-05	0.00011	CcSEcCtD
Reboxetine—Shock—Prednisone—hematologic cancer	3.02e-05	0.000109	CcSEcCtD
Reboxetine—Visual impairment—Doxorubicin—hematologic cancer	3.01e-05	0.000109	CcSEcCtD
Reboxetine—Nervous system disorder—Prednisone—hematologic cancer	3.01e-05	0.000109	CcSEcCtD
Reboxetine—Tachycardia—Prednisone—hematologic cancer	3e-05	0.000108	CcSEcCtD
Reboxetine—Skin disorder—Prednisone—hematologic cancer	2.98e-05	0.000108	CcSEcCtD
Reboxetine—Nausea—Gemcitabine—hematologic cancer	2.98e-05	0.000108	CcSEcCtD
Reboxetine—Vomiting—Cisplatin—hematologic cancer	2.97e-05	0.000107	CcSEcCtD
Reboxetine—Hyperhidrosis—Prednisone—hematologic cancer	2.97e-05	0.000107	CcSEcCtD
Reboxetine—Mental disorder—Epirubicin—hematologic cancer	2.96e-05	0.000107	CcSEcCtD
Reboxetine—Rash—Cisplatin—hematologic cancer	2.95e-05	0.000107	CcSEcCtD
Reboxetine—Dermatitis—Cisplatin—hematologic cancer	2.94e-05	0.000106	CcSEcCtD
Reboxetine—Malnutrition—Epirubicin—hematologic cancer	2.94e-05	0.000106	CcSEcCtD
Reboxetine—Diarrhoea—Etoposide—hematologic cancer	2.93e-05	0.000106	CcSEcCtD
Reboxetine—Anorexia—Prednisone—hematologic cancer	2.93e-05	0.000106	CcSEcCtD
Reboxetine—Eye disorder—Doxorubicin—hematologic cancer	2.92e-05	0.000106	CcSEcCtD
Reboxetine—Ill-defined disorder—Methotrexate—hematologic cancer	2.92e-05	0.000105	CcSEcCtD
Reboxetine—Tinnitus—Doxorubicin—hematologic cancer	2.92e-05	0.000105	CcSEcCtD
Reboxetine—Anaemia—Methotrexate—hematologic cancer	2.91e-05	0.000105	CcSEcCtD
Reboxetine—Feeling abnormal—Dexamethasone—hematologic cancer	2.9e-05	0.000105	CcSEcCtD
Reboxetine—Feeling abnormal—Betamethasone—hematologic cancer	2.9e-05	0.000105	CcSEcCtD
Reboxetine—Cardiac disorder—Doxorubicin—hematologic cancer	2.9e-05	0.000105	CcSEcCtD
Reboxetine—Tension—Epirubicin—hematologic cancer	2.89e-05	0.000104	CcSEcCtD
Reboxetine—Gastrointestinal pain—Betamethasone—hematologic cancer	2.88e-05	0.000104	CcSEcCtD
Reboxetine—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.88e-05	0.000104	CcSEcCtD
Reboxetine—Dysgeusia—Epirubicin—hematologic cancer	2.88e-05	0.000104	CcSEcCtD
Reboxetine—Hypersensitivity—Triamcinolone—hematologic cancer	2.86e-05	0.000103	CcSEcCtD
Reboxetine—Nervousness—Epirubicin—hematologic cancer	2.86e-05	0.000103	CcSEcCtD
Reboxetine—Angiopathy—Doxorubicin—hematologic cancer	2.84e-05	0.000103	CcSEcCtD
Reboxetine—Malaise—Methotrexate—hematologic cancer	2.83e-05	0.000102	CcSEcCtD
Reboxetine—Dizziness—Etoposide—hematologic cancer	2.83e-05	0.000102	CcSEcCtD
Reboxetine—Immune system disorder—Doxorubicin—hematologic cancer	2.82e-05	0.000102	CcSEcCtD
Reboxetine—Vertigo—Methotrexate—hematologic cancer	2.82e-05	0.000102	CcSEcCtD
Reboxetine—Mediastinal disorder—Doxorubicin—hematologic cancer	2.82e-05	0.000102	CcSEcCtD
Reboxetine—Leukopenia—Methotrexate—hematologic cancer	2.81e-05	0.000102	CcSEcCtD
Reboxetine—Chills—Doxorubicin—hematologic cancer	2.81e-05	0.000101	CcSEcCtD
Reboxetine—Urticaria—Betamethasone—hematologic cancer	2.8e-05	0.000101	CcSEcCtD
Reboxetine—Urticaria—Dexamethasone—hematologic cancer	2.8e-05	0.000101	CcSEcCtD
Reboxetine—Dizziness—Prednisolone—hematologic cancer	2.79e-05	0.000101	CcSEcCtD
Reboxetine—Asthenia—Triamcinolone—hematologic cancer	2.79e-05	0.000101	CcSEcCtD
Reboxetine—Body temperature increased—Dexamethasone—hematologic cancer	2.79e-05	0.000101	CcSEcCtD
Reboxetine—Body temperature increased—Betamethasone—hematologic cancer	2.79e-05	0.000101	CcSEcCtD
Reboxetine—Abdominal pain—Betamethasone—hematologic cancer	2.79e-05	0.000101	CcSEcCtD
Reboxetine—Abdominal pain—Dexamethasone—hematologic cancer	2.79e-05	0.000101	CcSEcCtD
Reboxetine—Nausea—Cisplatin—hematologic cancer	2.78e-05	0.0001	CcSEcCtD
Reboxetine—Insomnia—Prednisone—hematologic cancer	2.78e-05	0.0001	CcSEcCtD
Reboxetine—Paraesthesia—Prednisone—hematologic cancer	2.76e-05	9.96e-05	CcSEcCtD
Reboxetine—Mental disorder—Doxorubicin—hematologic cancer	2.74e-05	9.9e-05	CcSEcCtD
Reboxetine—Ill-defined disorder—Epirubicin—hematologic cancer	2.73e-05	9.87e-05	CcSEcCtD
Reboxetine—Vomiting—Etoposide—hematologic cancer	2.72e-05	9.84e-05	CcSEcCtD
Reboxetine—Malnutrition—Doxorubicin—hematologic cancer	2.72e-05	9.84e-05	CcSEcCtD
Reboxetine—Anaemia—Epirubicin—hematologic cancer	2.72e-05	9.83e-05	CcSEcCtD
Reboxetine—Agitation—Epirubicin—hematologic cancer	2.7e-05	9.77e-05	CcSEcCtD
Reboxetine—Dyspepsia—Prednisone—hematologic cancer	2.7e-05	9.77e-05	CcSEcCtD
Reboxetine—Rash—Etoposide—hematologic cancer	2.7e-05	9.76e-05	CcSEcCtD
Reboxetine—Dermatitis—Etoposide—hematologic cancer	2.7e-05	9.75e-05	CcSEcCtD
Reboxetine—Headache—Etoposide—hematologic cancer	2.68e-05	9.7e-05	CcSEcCtD
Reboxetine—Chest pain—Methotrexate—hematologic cancer	2.68e-05	9.67e-05	CcSEcCtD
Reboxetine—Tension—Doxorubicin—hematologic cancer	2.67e-05	9.65e-05	CcSEcCtD
Reboxetine—Decreased appetite—Prednisone—hematologic cancer	2.67e-05	9.65e-05	CcSEcCtD
Reboxetine—Dysgeusia—Doxorubicin—hematologic cancer	2.67e-05	9.63e-05	CcSEcCtD
Reboxetine—Rash—Prednisolone—hematologic cancer	2.66e-05	9.63e-05	CcSEcCtD
Reboxetine—Dermatitis—Prednisolone—hematologic cancer	2.66e-05	9.62e-05	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.66e-05	9.61e-05	CcSEcCtD
Reboxetine—Malaise—Epirubicin—hematologic cancer	2.65e-05	9.59e-05	CcSEcCtD
Reboxetine—Headache—Prednisolone—hematologic cancer	2.65e-05	9.57e-05	CcSEcCtD
Reboxetine—Discomfort—Methotrexate—hematologic cancer	2.64e-05	9.56e-05	CcSEcCtD
Reboxetine—Nervousness—Doxorubicin—hematologic cancer	2.64e-05	9.56e-05	CcSEcCtD
Reboxetine—Vertigo—Epirubicin—hematologic cancer	2.64e-05	9.55e-05	CcSEcCtD
Reboxetine—Syncope—Epirubicin—hematologic cancer	2.64e-05	9.54e-05	CcSEcCtD
Reboxetine—Leukopenia—Epirubicin—hematologic cancer	2.63e-05	9.52e-05	CcSEcCtD
Reboxetine—Constipation—Prednisone—hematologic cancer	2.62e-05	9.49e-05	CcSEcCtD
Reboxetine—Palpitations—Epirubicin—hematologic cancer	2.6e-05	9.4e-05	CcSEcCtD
Reboxetine—Confusional state—Methotrexate—hematologic cancer	2.59e-05	9.35e-05	CcSEcCtD
Reboxetine—Loss of consciousness—Epirubicin—hematologic cancer	2.59e-05	9.35e-05	CcSEcCtD
Reboxetine—Dizziness—Triamcinolone—hematologic cancer	2.57e-05	9.29e-05	CcSEcCtD
Reboxetine—Infection—Methotrexate—hematologic cancer	2.55e-05	9.21e-05	CcSEcCtD
Reboxetine—Nausea—Etoposide—hematologic cancer	2.54e-05	9.2e-05	CcSEcCtD
Reboxetine—Hypertension—Epirubicin—hematologic cancer	2.54e-05	9.18e-05	CcSEcCtD
Reboxetine—Feeling abnormal—Prednisone—hematologic cancer	2.53e-05	9.14e-05	CcSEcCtD
Reboxetine—Asthenia—Dexamethasone—hematologic cancer	2.53e-05	9.14e-05	CcSEcCtD
Reboxetine—Asthenia—Betamethasone—hematologic cancer	2.53e-05	9.14e-05	CcSEcCtD
Reboxetine—Ill-defined disorder—Doxorubicin—hematologic cancer	2.53e-05	9.13e-05	CcSEcCtD
Reboxetine—Nervous system disorder—Methotrexate—hematologic cancer	2.52e-05	9.09e-05	CcSEcCtD
Reboxetine—Anaemia—Doxorubicin—hematologic cancer	2.52e-05	9.09e-05	CcSEcCtD
Reboxetine—Gastrointestinal pain—Prednisone—hematologic cancer	2.51e-05	9.07e-05	CcSEcCtD
Reboxetine—Nausea—Prednisolone—hematologic cancer	2.51e-05	9.07e-05	CcSEcCtD
Reboxetine—Chest pain—Epirubicin—hematologic cancer	2.5e-05	9.05e-05	CcSEcCtD
Reboxetine—Agitation—Doxorubicin—hematologic cancer	2.5e-05	9.04e-05	CcSEcCtD
Reboxetine—Anxiety—Epirubicin—hematologic cancer	2.5e-05	9.02e-05	CcSEcCtD
Reboxetine—Skin disorder—Methotrexate—hematologic cancer	2.49e-05	9.01e-05	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.49e-05	8.99e-05	CcSEcCtD
Reboxetine—Hyperhidrosis—Methotrexate—hematologic cancer	2.48e-05	8.96e-05	CcSEcCtD
Reboxetine—Discomfort—Epirubicin—hematologic cancer	2.47e-05	8.94e-05	CcSEcCtD
Reboxetine—Vomiting—Triamcinolone—hematologic cancer	2.47e-05	8.93e-05	CcSEcCtD
Reboxetine—Malaise—Doxorubicin—hematologic cancer	2.45e-05	8.87e-05	CcSEcCtD
Reboxetine—Rash—Triamcinolone—hematologic cancer	2.45e-05	8.85e-05	CcSEcCtD
Reboxetine—Dry mouth—Epirubicin—hematologic cancer	2.45e-05	8.85e-05	CcSEcCtD
Reboxetine—Dermatitis—Triamcinolone—hematologic cancer	2.45e-05	8.85e-05	CcSEcCtD
Reboxetine—Vertigo—Doxorubicin—hematologic cancer	2.45e-05	8.84e-05	CcSEcCtD
Reboxetine—Anorexia—Methotrexate—hematologic cancer	2.45e-05	8.84e-05	CcSEcCtD
Reboxetine—Syncope—Doxorubicin—hematologic cancer	2.44e-05	8.82e-05	CcSEcCtD
Reboxetine—Urticaria—Prednisone—hematologic cancer	2.44e-05	8.81e-05	CcSEcCtD
Reboxetine—Leukopenia—Doxorubicin—hematologic cancer	2.44e-05	8.81e-05	CcSEcCtD
Reboxetine—Headache—Triamcinolone—hematologic cancer	2.43e-05	8.8e-05	CcSEcCtD
Reboxetine—Abdominal pain—Prednisone—hematologic cancer	2.43e-05	8.77e-05	CcSEcCtD
Reboxetine—Body temperature increased—Prednisone—hematologic cancer	2.43e-05	8.77e-05	CcSEcCtD
Reboxetine—Confusional state—Epirubicin—hematologic cancer	2.42e-05	8.75e-05	CcSEcCtD
Reboxetine—Diarrhoea—Dexamethasone—hematologic cancer	2.41e-05	8.72e-05	CcSEcCtD
Reboxetine—Diarrhoea—Betamethasone—hematologic cancer	2.41e-05	8.72e-05	CcSEcCtD
Reboxetine—Palpitations—Doxorubicin—hematologic cancer	2.41e-05	8.69e-05	CcSEcCtD
Reboxetine—Hypotension—Methotrexate—hematologic cancer	2.4e-05	8.66e-05	CcSEcCtD
Reboxetine—Loss of consciousness—Doxorubicin—hematologic cancer	2.39e-05	8.65e-05	CcSEcCtD
Reboxetine—Infection—Epirubicin—hematologic cancer	2.38e-05	8.62e-05	CcSEcCtD
Reboxetine—Shock—Epirubicin—hematologic cancer	2.36e-05	8.54e-05	CcSEcCtD
Reboxetine—Nervous system disorder—Epirubicin—hematologic cancer	2.35e-05	8.51e-05	CcSEcCtD
Reboxetine—Hypertension—Doxorubicin—hematologic cancer	2.35e-05	8.49e-05	CcSEcCtD
Reboxetine—Tachycardia—Epirubicin—hematologic cancer	2.34e-05	8.47e-05	CcSEcCtD
Reboxetine—Skin disorder—Epirubicin—hematologic cancer	2.33e-05	8.43e-05	CcSEcCtD
Reboxetine—Dizziness—Betamethasone—hematologic cancer	2.33e-05	8.43e-05	CcSEcCtD
Reboxetine—Dizziness—Dexamethasone—hematologic cancer	2.33e-05	8.43e-05	CcSEcCtD
Reboxetine—Hyperhidrosis—Epirubicin—hematologic cancer	2.32e-05	8.39e-05	CcSEcCtD
Reboxetine—Insomnia—Methotrexate—hematologic cancer	2.32e-05	8.39e-05	CcSEcCtD
Reboxetine—Chest pain—Doxorubicin—hematologic cancer	2.32e-05	8.38e-05	CcSEcCtD
Reboxetine—Anxiety—Doxorubicin—hematologic cancer	2.31e-05	8.35e-05	CcSEcCtD
Reboxetine—Nausea—Triamcinolone—hematologic cancer	2.31e-05	8.34e-05	CcSEcCtD
Reboxetine—Paraesthesia—Methotrexate—hematologic cancer	2.3e-05	8.33e-05	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.3e-05	8.32e-05	CcSEcCtD
Reboxetine—Discomfort—Doxorubicin—hematologic cancer	2.29e-05	8.28e-05	CcSEcCtD
Reboxetine—Anorexia—Epirubicin—hematologic cancer	2.29e-05	8.27e-05	CcSEcCtD
Reboxetine—Dyspnoea—Methotrexate—hematologic cancer	2.29e-05	8.27e-05	CcSEcCtD
Reboxetine—Somnolence—Methotrexate—hematologic cancer	2.28e-05	8.24e-05	CcSEcCtD
Reboxetine—Dry mouth—Doxorubicin—hematologic cancer	2.27e-05	8.19e-05	CcSEcCtD
Reboxetine—Hypersensitivity—Prednisone—hematologic cancer	2.26e-05	8.17e-05	CcSEcCtD
Reboxetine—Dyspepsia—Methotrexate—hematologic cancer	2.26e-05	8.16e-05	CcSEcCtD
Reboxetine—Hypotension—Epirubicin—hematologic cancer	2.24e-05	8.11e-05	CcSEcCtD
Reboxetine—Vomiting—Betamethasone—hematologic cancer	2.24e-05	8.1e-05	CcSEcCtD
Reboxetine—Vomiting—Dexamethasone—hematologic cancer	2.24e-05	8.1e-05	CcSEcCtD
Reboxetine—Confusional state—Doxorubicin—hematologic cancer	2.24e-05	8.1e-05	CcSEcCtD
Reboxetine—Decreased appetite—Methotrexate—hematologic cancer	2.23e-05	8.06e-05	CcSEcCtD
Reboxetine—Rash—Betamethasone—hematologic cancer	2.22e-05	8.03e-05	CcSEcCtD
Reboxetine—Rash—Dexamethasone—hematologic cancer	2.22e-05	8.03e-05	CcSEcCtD
Reboxetine—Dermatitis—Dexamethasone—hematologic cancer	2.22e-05	8.03e-05	CcSEcCtD
Reboxetine—Dermatitis—Betamethasone—hematologic cancer	2.22e-05	8.03e-05	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.21e-05	8.01e-05	CcSEcCtD
Reboxetine—Headache—Dexamethasone—hematologic cancer	2.21e-05	7.98e-05	CcSEcCtD
Reboxetine—Headache—Betamethasone—hematologic cancer	2.21e-05	7.98e-05	CcSEcCtD
Reboxetine—Infection—Doxorubicin—hematologic cancer	2.21e-05	7.98e-05	CcSEcCtD
Reboxetine—Asthenia—Prednisone—hematologic cancer	2.2e-05	7.96e-05	CcSEcCtD
Reboxetine—Shock—Doxorubicin—hematologic cancer	2.19e-05	7.9e-05	CcSEcCtD
Reboxetine—Nervous system disorder—Doxorubicin—hematologic cancer	2.18e-05	7.87e-05	CcSEcCtD
Reboxetine—Insomnia—Epirubicin—hematologic cancer	2.17e-05	7.85e-05	CcSEcCtD
Reboxetine—Tachycardia—Doxorubicin—hematologic cancer	2.17e-05	7.84e-05	CcSEcCtD
Reboxetine—Skin disorder—Doxorubicin—hematologic cancer	2.16e-05	7.8e-05	CcSEcCtD
Reboxetine—Paraesthesia—Epirubicin—hematologic cancer	2.16e-05	7.79e-05	CcSEcCtD
Reboxetine—Hyperhidrosis—Doxorubicin—hematologic cancer	2.15e-05	7.76e-05	CcSEcCtD
Reboxetine—Dyspnoea—Epirubicin—hematologic cancer	2.14e-05	7.74e-05	CcSEcCtD
Reboxetine—Somnolence—Epirubicin—hematologic cancer	2.13e-05	7.71e-05	CcSEcCtD
Reboxetine—Anorexia—Doxorubicin—hematologic cancer	2.12e-05	7.65e-05	CcSEcCtD
Reboxetine—Feeling abnormal—Methotrexate—hematologic cancer	2.11e-05	7.64e-05	CcSEcCtD
Reboxetine—Dyspepsia—Epirubicin—hematologic cancer	2.11e-05	7.64e-05	CcSEcCtD
Reboxetine—Diarrhoea—Prednisone—hematologic cancer	2.1e-05	7.59e-05	CcSEcCtD
Reboxetine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.1e-05	7.58e-05	CcSEcCtD
Reboxetine—Nausea—Dexamethasone—hematologic cancer	2.09e-05	7.57e-05	CcSEcCtD
Reboxetine—Nausea—Betamethasone—hematologic cancer	2.09e-05	7.57e-05	CcSEcCtD
Reboxetine—Decreased appetite—Epirubicin—hematologic cancer	2.09e-05	7.54e-05	CcSEcCtD
Reboxetine—Hypotension—Doxorubicin—hematologic cancer	2.08e-05	7.5e-05	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.07e-05	7.49e-05	CcSEcCtD
Reboxetine—Constipation—Epirubicin—hematologic cancer	2.05e-05	7.42e-05	CcSEcCtD
Reboxetine—Urticaria—Methotrexate—hematologic cancer	2.04e-05	7.37e-05	CcSEcCtD
Reboxetine—Dizziness—Prednisone—hematologic cancer	2.03e-05	7.34e-05	CcSEcCtD
Reboxetine—Body temperature increased—Methotrexate—hematologic cancer	2.03e-05	7.33e-05	CcSEcCtD
Reboxetine—Abdominal pain—Methotrexate—hematologic cancer	2.03e-05	7.33e-05	CcSEcCtD
Reboxetine—Insomnia—Doxorubicin—hematologic cancer	2.01e-05	7.26e-05	CcSEcCtD
Reboxetine—Paraesthesia—Doxorubicin—hematologic cancer	1.99e-05	7.21e-05	CcSEcCtD
Reboxetine—Dyspnoea—Doxorubicin—hematologic cancer	1.98e-05	7.16e-05	CcSEcCtD
Reboxetine—Feeling abnormal—Epirubicin—hematologic cancer	1.98e-05	7.15e-05	CcSEcCtD
Reboxetine—Somnolence—Doxorubicin—hematologic cancer	1.97e-05	7.14e-05	CcSEcCtD
Reboxetine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.96e-05	7.1e-05	CcSEcCtD
Reboxetine—Dyspepsia—Doxorubicin—hematologic cancer	1.96e-05	7.07e-05	CcSEcCtD
Reboxetine—Vomiting—Prednisone—hematologic cancer	1.95e-05	7.05e-05	CcSEcCtD
Reboxetine—Rash—Prednisone—hematologic cancer	1.94e-05	7e-05	CcSEcCtD
Reboxetine—Dermatitis—Prednisone—hematologic cancer	1.93e-05	6.99e-05	CcSEcCtD
Reboxetine—Decreased appetite—Doxorubicin—hematologic cancer	1.93e-05	6.98e-05	CcSEcCtD
Reboxetine—Headache—Prednisone—hematologic cancer	1.92e-05	6.95e-05	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.92e-05	6.93e-05	CcSEcCtD
Reboxetine—Urticaria—Epirubicin—hematologic cancer	1.91e-05	6.89e-05	CcSEcCtD
Reboxetine—Constipation—Doxorubicin—hematologic cancer	1.9e-05	6.87e-05	CcSEcCtD
Reboxetine—Body temperature increased—Epirubicin—hematologic cancer	1.9e-05	6.86e-05	CcSEcCtD
Reboxetine—Abdominal pain—Epirubicin—hematologic cancer	1.9e-05	6.86e-05	CcSEcCtD
Reboxetine—Hypersensitivity—Methotrexate—hematologic cancer	1.89e-05	6.83e-05	CcSEcCtD
Reboxetine—Asthenia—Methotrexate—hematologic cancer	1.84e-05	6.65e-05	CcSEcCtD
Reboxetine—Feeling abnormal—Doxorubicin—hematologic cancer	1.83e-05	6.62e-05	CcSEcCtD
Reboxetine—Nausea—Prednisone—hematologic cancer	1.82e-05	6.59e-05	CcSEcCtD
Reboxetine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.82e-05	6.57e-05	CcSEcCtD
Reboxetine—Hypersensitivity—Epirubicin—hematologic cancer	1.77e-05	6.39e-05	CcSEcCtD
Reboxetine—Urticaria—Doxorubicin—hematologic cancer	1.76e-05	6.38e-05	CcSEcCtD
Reboxetine—Abdominal pain—Doxorubicin—hematologic cancer	1.76e-05	6.35e-05	CcSEcCtD
Reboxetine—Body temperature increased—Doxorubicin—hematologic cancer	1.76e-05	6.35e-05	CcSEcCtD
Reboxetine—Diarrhoea—Methotrexate—hematologic cancer	1.76e-05	6.34e-05	CcSEcCtD
Reboxetine—Asthenia—Epirubicin—hematologic cancer	1.72e-05	6.23e-05	CcSEcCtD
Reboxetine—Dizziness—Methotrexate—hematologic cancer	1.7e-05	6.13e-05	CcSEcCtD
Reboxetine—Diarrhoea—Epirubicin—hematologic cancer	1.64e-05	5.94e-05	CcSEcCtD
Reboxetine—Hypersensitivity—Doxorubicin—hematologic cancer	1.64e-05	5.92e-05	CcSEcCtD
Reboxetine—Vomiting—Methotrexate—hematologic cancer	1.63e-05	5.9e-05	CcSEcCtD
Reboxetine—Rash—Methotrexate—hematologic cancer	1.62e-05	5.85e-05	CcSEcCtD
Reboxetine—Dermatitis—Methotrexate—hematologic cancer	1.62e-05	5.84e-05	CcSEcCtD
Reboxetine—Headache—Methotrexate—hematologic cancer	1.61e-05	5.81e-05	CcSEcCtD
Reboxetine—Asthenia—Doxorubicin—hematologic cancer	1.59e-05	5.76e-05	CcSEcCtD
Reboxetine—Dizziness—Epirubicin—hematologic cancer	1.59e-05	5.74e-05	CcSEcCtD
Reboxetine—Vomiting—Epirubicin—hematologic cancer	1.53e-05	5.52e-05	CcSEcCtD
Reboxetine—Nausea—Methotrexate—hematologic cancer	1.52e-05	5.51e-05	CcSEcCtD
Reboxetine—Diarrhoea—Doxorubicin—hematologic cancer	1.52e-05	5.49e-05	CcSEcCtD
Reboxetine—Rash—Epirubicin—hematologic cancer	1.51e-05	5.47e-05	CcSEcCtD
Reboxetine—Dermatitis—Epirubicin—hematologic cancer	1.51e-05	5.47e-05	CcSEcCtD
Reboxetine—Headache—Epirubicin—hematologic cancer	1.5e-05	5.44e-05	CcSEcCtD
Reboxetine—Dizziness—Doxorubicin—hematologic cancer	1.47e-05	5.31e-05	CcSEcCtD
Reboxetine—Nausea—Epirubicin—hematologic cancer	1.43e-05	5.15e-05	CcSEcCtD
Reboxetine—Vomiting—Doxorubicin—hematologic cancer	1.41e-05	5.11e-05	CcSEcCtD
Reboxetine—Rash—Doxorubicin—hematologic cancer	1.4e-05	5.06e-05	CcSEcCtD
Reboxetine—Dermatitis—Doxorubicin—hematologic cancer	1.4e-05	5.06e-05	CcSEcCtD
Reboxetine—Headache—Doxorubicin—hematologic cancer	1.39e-05	5.03e-05	CcSEcCtD
Reboxetine—Nausea—Doxorubicin—hematologic cancer	1.32e-05	4.77e-05	CcSEcCtD
Reboxetine—HTR2C—Signaling Pathways—PTGER4—hematologic cancer	1e-05	0.000237	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HDC—hematologic cancer	9.98e-06	0.000236	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—LCK—hematologic cancer	9.97e-06	0.000236	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	9.9e-06	0.000234	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HMMR—hematologic cancer	9.84e-06	0.000232	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—IDH2—hematologic cancer	9.84e-06	0.000232	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ARNTL—hematologic cancer	9.81e-06	0.000232	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—H3F3A—hematologic cancer	9.77e-06	0.000231	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	9.63e-06	0.000228	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	9.61e-06	0.000227	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CA9—hematologic cancer	9.55e-06	0.000226	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ACP5—hematologic cancer	9.55e-06	0.000226	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PRKCZ—hematologic cancer	9.5e-06	0.000225	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NCOR2—hematologic cancer	9.42e-06	0.000223	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3CG—hematologic cancer	9.29e-06	0.000219	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ARNTL—hematologic cancer	9.25e-06	0.000219	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PARP1—hematologic cancer	9.18e-06	0.000217	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CDA—hematologic cancer	9.13e-06	0.000216	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FBXW7—hematologic cancer	9.03e-06	0.000213	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ACP5—hematologic cancer	9e-06	0.000213	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CA9—hematologic cancer	9e-06	0.000213	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—IDH1—hematologic cancer	8.98e-06	0.000212	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	8.97e-06	0.000212	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	8.9e-06	0.00021	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NCOR2—hematologic cancer	8.88e-06	0.00021	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ABCC3—hematologic cancer	8.88e-06	0.00021	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTO1—hematologic cancer	8.88e-06	0.00021	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—TXN—hematologic cancer	8.88e-06	0.00021	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HDAC2—hematologic cancer	8.85e-06	0.000209	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CXCR4—hematologic cancer	8.85e-06	0.000209	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PC—hematologic cancer	8.79e-06	0.000208	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SPHK1—hematologic cancer	8.69e-06	0.000205	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CBL—hematologic cancer	8.63e-06	0.000204	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL3—hematologic cancer	8.54e-06	0.000202	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GBA—hematologic cancer	8.49e-06	0.000201	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	8.49e-06	0.000201	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—IDH1—hematologic cancer	8.46e-06	0.0002	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3CG—hematologic cancer	8.43e-06	0.000199	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PTPN1—hematologic cancer	8.39e-06	0.000198	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCC3—hematologic cancer	8.36e-06	0.000198	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTO1—hematologic cancer	8.36e-06	0.000198	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—TXN—hematologic cancer	8.36e-06	0.000198	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—UGT1A1—hematologic cancer	8.34e-06	0.000197	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PTPN11—hematologic cancer	8.29e-06	0.000196	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—RASGRP1—hematologic cancer	8.26e-06	0.000195	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HSP90AA1—hematologic cancer	8.23e-06	0.000195	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SYK—hematologic cancer	8.23e-06	0.000195	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SPHK1—hematologic cancer	8.18e-06	0.000193	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	8.18e-06	0.000193	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3CD—hematologic cancer	8.16e-06	0.000193	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SLC22A1—hematologic cancer	8.12e-06	0.000192	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CRABP1—hematologic cancer	8.12e-06	0.000192	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CREB1—hematologic cancer	8.03e-06	0.00019	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—STAT1—hematologic cancer	7.94e-06	0.000188	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALOX5—hematologic cancer	7.91e-06	0.000187	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	7.91e-06	0.000187	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	7.86e-06	0.000186	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CCL2—hematologic cancer	7.85e-06	0.000186	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL6R—hematologic cancer	7.83e-06	0.000185	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MTAP—hematologic cancer	7.76e-06	0.000183	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3R1—hematologic cancer	7.71e-06	0.000182	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NUP98—hematologic cancer	7.66e-06	0.000181	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	7.65e-06	0.000181	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CRABP1—hematologic cancer	7.65e-06	0.000181	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—JAK2—hematologic cancer	7.49e-06	0.000177	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—MAP2K1—hematologic cancer	7.46e-06	0.000176	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALOX5—hematologic cancer	7.45e-06	0.000176	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NCOA3—hematologic cancer	7.44e-06	0.000176	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ADCY7—hematologic cancer	7.44e-06	0.000176	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GRB2—hematologic cancer	7.43e-06	0.000175	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3CD—hematologic cancer	7.41e-06	0.000175	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PDGFA—hematologic cancer	7.41e-06	0.000175	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NUP214—hematologic cancer	7.39e-06	0.000175	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KITLG—hematologic cancer	7.3e-06	0.000173	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MTR—hematologic cancer	7.24e-06	0.000171	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ABCG2—hematologic cancer	7.24e-06	0.000171	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NUP98—hematologic cancer	7.22e-06	0.000171	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—STAT5A—hematologic cancer	7.14e-06	0.000169	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3CB—hematologic cancer	7.12e-06	0.000168	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ENO2—hematologic cancer	7.1e-06	0.000168	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CDKN2B—hematologic cancer	7.07e-06	0.000167	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ADCY7—hematologic cancer	7.01e-06	0.000166	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NCOA3—hematologic cancer	7.01e-06	0.000166	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3R1—hematologic cancer	7e-06	0.000165	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NUP214—hematologic cancer	6.96e-06	0.000164	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—FHL2—hematologic cancer	6.92e-06	0.000163	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTT1—hematologic cancer	6.88e-06	0.000163	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CD86—hematologic cancer	6.84e-06	0.000162	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MTR—hematologic cancer	6.82e-06	0.000161	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCG2—hematologic cancer	6.82e-06	0.000161	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—JAK2—hematologic cancer	6.8e-06	0.000161	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AGRN—hematologic cancer	6.78e-06	0.00016	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HES1—hematologic cancer	6.75e-06	0.000159	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SDC1—hematologic cancer	6.73e-06	0.000159	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NCOR1—hematologic cancer	6.71e-06	0.000159	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ENO2—hematologic cancer	6.69e-06	0.000158	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.68e-06	0.000158	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FGF1—hematologic cancer	6.63e-06	0.000157	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CSF2—hematologic cancer	6.63e-06	0.000157	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FOXO1—hematologic cancer	6.54e-06	0.000155	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—IL2—hematologic cancer	6.54e-06	0.000154	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PDGFRB—hematologic cancer	6.53e-06	0.000154	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTT1—hematologic cancer	6.49e-06	0.000153	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3CB—hematologic cancer	6.46e-06	0.000153	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.44e-06	0.000152	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—IDH2—hematologic cancer	6.43e-06	0.000152	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HMMR—hematologic cancer	6.43e-06	0.000152	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PDGFRA—hematologic cancer	6.43e-06	0.000152	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PRKCG—hematologic cancer	6.4e-06	0.000151	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—JAK1—hematologic cancer	6.4e-06	0.000151	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SDC1—hematologic cancer	6.34e-06	0.00015	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.05e-06	0.000143	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	6.03e-06	0.000143	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL2RA—hematologic cancer	5.98e-06	0.000141	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL2—hematologic cancer	5.93e-06	0.00014	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TERT—hematologic cancer	5.91e-06	0.00014	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CA9—hematologic cancer	5.88e-06	0.000139	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ACP5—hematologic cancer	5.88e-06	0.000139	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.81e-06	0.000137	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PDGFB—hematologic cancer	5.77e-06	0.000136	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CD44—hematologic cancer	5.72e-06	0.000135	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NQO1—hematologic cancer	5.72e-06	0.000135	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TSC2—hematologic cancer	5.64e-06	0.000133	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—IDH1—hematologic cancer	5.53e-06	0.000131	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.47e-06	0.000129	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.47e-06	0.000129	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—TXN—hematologic cancer	5.47e-06	0.000129	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FGFR3—hematologic cancer	5.43e-06	0.000128	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYCS—hematologic cancer	5.41e-06	0.000128	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NQO1—hematologic cancer	5.39e-06	0.000127	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CD44—hematologic cancer	5.39e-06	0.000127	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	5.38e-06	0.000127	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAPK14—hematologic cancer	5.37e-06	0.000127	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.35e-06	0.000126	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ESR1—hematologic cancer	5.27e-06	0.000125	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FN1—hematologic cancer	5.21e-06	0.000123	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NFKBIA—hematologic cancer	5.14e-06	0.000122	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—BAD—hematologic cancer	5.14e-06	0.000122	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.14e-06	0.000122	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYCS—hematologic cancer	5.1e-06	0.000121	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NOTCH1—hematologic cancer	5.09e-06	0.00012	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	5.07e-06	0.00012	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CRABP1—hematologic cancer	5e-06	0.000118	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5e-06	0.000118	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CD80—hematologic cancer	4.99e-06	0.000118	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CG—hematologic cancer	4.98e-06	0.000118	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KIT—hematologic cancer	4.98e-06	0.000118	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—NRAS—hematologic cancer	4.98e-06	0.000118	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PTPN11—hematologic cancer	4.89e-06	0.000116	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.87e-06	0.000115	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—MAPK3—hematologic cancer	4.77e-06	0.000113	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTP1—hematologic cancer	4.77e-06	0.000113	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CREB1—hematologic cancer	4.74e-06	0.000112	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NUP98—hematologic cancer	4.72e-06	0.000112	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—BRAF—hematologic cancer	4.68e-06	0.000111	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCL2—hematologic cancer	4.64e-06	0.00011	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL6R—hematologic cancer	4.63e-06	0.000109	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CREBBP—hematologic cancer	4.62e-06	0.000109	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.58e-06	0.000108	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.58e-06	0.000108	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NUP214—hematologic cancer	4.55e-06	0.000108	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.5e-06	0.000106	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.46e-06	0.000105	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MTR—hematologic cancer	4.46e-06	0.000105	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAP2K1—hematologic cancer	4.41e-06	0.000104	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NCOR1—hematologic cancer	4.38e-06	0.000104	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTM1—hematologic cancer	4.38e-06	0.000104	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CD—hematologic cancer	4.38e-06	0.000104	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ENO2—hematologic cancer	4.37e-06	0.000103	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3CA—hematologic cancer	4.34e-06	0.000103	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—KRAS—hematologic cancer	4.29e-06	0.000101	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.26e-06	0.000101	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.24e-06	0.0001	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FGF2—hematologic cancer	4.19e-06	9.91e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SDC1—hematologic cancer	4.14e-06	9.79e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3R1—hematologic cancer	4.14e-06	9.77e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.13e-06	9.76e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.13e-06	9.76e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—JAK2—hematologic cancer	4.02e-06	9.5e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3CA—hematologic cancer	3.94e-06	9.31e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MDM2—hematologic cancer	3.92e-06	9.27e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MTHFR—hematologic cancer	3.87e-06	9.16e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MTOR—hematologic cancer	3.82e-06	9.02e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CB—hematologic cancer	3.82e-06	9.02e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.65e-06	8.63e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HRAS—hematologic cancer	3.64e-06	8.61e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CDKN1B—hematologic cancer	3.58e-06	8.47e-05	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AKT1—hematologic cancer	3.54e-06	8.38e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CD44—hematologic cancer	3.52e-06	8.33e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NQO1—hematologic cancer	3.52e-06	8.33e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CASP3—hematologic cancer	3.51e-06	8.3e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL2—hematologic cancer	3.51e-06	8.29e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL6—hematologic cancer	3.49e-06	8.24e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCND1—hematologic cancer	3.42e-06	8.08e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—JUN—hematologic cancer	3.41e-06	8.06e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYCS—hematologic cancer	3.33e-06	7.88e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.31e-06	7.83e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CDKN1A—hematologic cancer	3.31e-06	7.81e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PTEN—hematologic cancer	3.3e-06	7.8e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CG—hematologic cancer	3.25e-06	7.69e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAPK8—hematologic cancer	3.23e-06	7.63e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AKT1—hematologic cancer	3.22e-06	7.61e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EP300—hematologic cancer	3.15e-06	7.43e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.07e-06	7.25e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SRC—hematologic cancer	3.06e-06	7.23e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CREBBP—hematologic cancer	3.02e-06	7.13e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—VEGFA—hematologic cancer	2.98e-06	7.04e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—STAT3—hematologic cancer	2.95e-06	6.97e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NRAS—hematologic cancer	2.94e-06	6.96e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.94e-06	6.95e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.86e-06	6.76e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.84e-06	6.72e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALB—hematologic cancer	2.82e-06	6.68e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAPK3—hematologic cancer	2.82e-06	6.66e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.78e-06	6.57e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MYC—hematologic cancer	2.74e-06	6.48e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	2.73e-06	6.46e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.7e-06	6.39e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.7e-06	6.38e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.7e-06	6.38e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.7e-06	6.37e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALB—hematologic cancer	2.66e-06	6.29e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.55e-06	6.02e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KRAS—hematologic cancer	2.53e-06	5.99e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.49e-06	5.89e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.39e-06	5.64e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.35e-06	5.55e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	2.33e-06	5.5e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TP53—hematologic cancer	2.25e-06	5.32e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PTEN—hematologic cancer	2.16e-06	5.09e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HRAS—hematologic cancer	2.15e-06	5.09e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL6—hematologic cancer	2.06e-06	4.87e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—EP300—hematologic cancer	2.06e-06	4.86e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PTEN—hematologic cancer	2.03e-06	4.8e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.01e-06	4.74e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—EP300—hematologic cancer	1.94e-06	4.58e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKT1—hematologic cancer	1.9e-06	4.49e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.86e-06	4.39e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.76e-06	4.17e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALB—hematologic cancer	1.74e-06	4.11e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.66e-06	3.93e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.54e-06	3.63e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.52e-06	3.59e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.43e-06	3.39e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.33e-06	3.14e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—EP300—hematologic cancer	1.27e-06	2.99e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AKT1—hematologic cancer	1.24e-06	2.94e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.17e-06	2.77e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	9.37e-07	2.21e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AKT1—hematologic cancer	7.65e-07	1.81e-05	CbGpPWpGaD
